Doceree, a prominent healthcare marketing platform, has officially launched Semmelweis, a groundbreaking pharma-specific reasoning and orchestration model designed explicitly for the pharmaceutical sector. Operating...
Aureka, an innovative TechBio corporation specializing in advanced infrastructure for AI-powered biologics discovery, officially announced the debut of its Open Drug Discovery Engine (OpenDDE)....
Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform,...
As part of the latest consolidation in the life sciences industry, Klick Health, which is the largest independent company, has announced the acquisition of...
Inductive's global ADMET prediction models are now available as a connector for Claude, enabling any drug discovery scientist working with Claude to access state-of-the-art...
Within3, the leading Launch Intelligence platform for life sciences, announced the appointment of Erin Mistry as Chief Executive Officer. Mistry brings more than 20...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, a Korean-based company leads the way in biotech innovation with...
Combining human iPSC biology and AI computing to accelerate drug discovery, improve drug safety, and advance precision medicine.
Greenstone Biosciences, Inc. announces a collaboration with Intel Corp. to accelerate...
Partnership expands access to next-generation protein quantitation technology across Japan's biopharmaceutical and life sciences markets
Nirrin Technologies, a developer of analytical tools designed to transform...
First partnership announced under Verge Labs' platform-first model; Tenacia will apply Verge's AI platform and proprietary multimodal human tissue data to characterize targets across...